News | 06 August 2012
For years now, the makers of brand-name and generic prescription drugs have worked together in a collusive practice that adds billions of dollars to the cost of health care. The practice is nicknamed pay-for-delay?the "delay" being the longer stretch ...
Click on the link to read the full article at Chicago Tribune
(This link will open in a new window)